| Primary |
| Type 2 Diabetes Mellitus |
16.6% |
| Glucose Tolerance Impaired |
16.1% |
| Hypertension |
15.2% |
| Cardiovascular Disorder |
14.8% |
| Diabetes Mellitus |
12.1% |
| Constipation |
4.0% |
| Diabetes Mellitus Non-insulin-dependent |
3.6% |
| Product Used For Unknown Indication |
3.1% |
| Epilepsy |
1.8% |
| Blood Glucose |
1.3% |
| Cardiac Failure Chronic |
1.3% |
| Depression |
1.3% |
| Gastric Ulcer |
1.3% |
| Hepatic Cirrhosis |
1.3% |
| Pruritus |
1.3% |
| Arrhythmia |
0.9% |
| Dyslipidaemia |
0.9% |
| Hyperlipidaemia |
0.9% |
| Pityriasis Rosea |
0.9% |
| Prophylaxis |
0.9% |
|
| Small Intestinal Haemorrhage |
19.0% |
| Vomiting |
15.9% |
| Gastrooesophageal Reflux Disease |
6.3% |
| Product Substitution Issue |
4.8% |
| Reflux Oesophagitis |
4.8% |
| Renal Impairment |
4.8% |
| Blood Glucose Increased |
3.2% |
| Diabetes Mellitus Inadequate Control |
3.2% |
| Drug Eruption |
3.2% |
| High Density Lipoprotein Decreased |
3.2% |
| Liver Disorder |
3.2% |
| Maternal Exposure During Pregnancy |
3.2% |
| Palpitations |
3.2% |
| Pruritus |
3.2% |
| Renal Failure Acute |
3.2% |
| Skin Irritation |
3.2% |
| Type 1 Diabetes Mellitus |
3.2% |
| Ureteral Stent Insertion |
3.2% |
| Vascular Graft |
3.2% |
| Ventricular Tachycardia |
3.2% |
|
| Secondary |
| Product Used For Unknown Indication |
20.8% |
| Cardiovascular Disorder |
16.5% |
| Glucose Tolerance Impaired |
14.8% |
| Hypertension |
10.8% |
| Diabetes Mellitus |
7.7% |
| Type 2 Diabetes Mellitus |
7.7% |
| Diabetes Mellitus Non-insulin-dependent |
4.8% |
| Breast Cancer |
2.6% |
| Constipation |
2.6% |
| Gastric Ulcer |
1.8% |
| Drug Use For Unknown Indication |
1.6% |
| Depression |
1.3% |
| Blood Glucose |
0.9% |
| Cardiac Failure Chronic |
0.9% |
| Febrile Neutropenia |
0.9% |
| Hepatic Cirrhosis |
0.9% |
| Insulin-requiring Type Ii Diabetes Mellitus |
0.9% |
| Pruritus |
0.9% |
| Restlessness |
0.9% |
| Dyslipidaemia |
0.7% |
|
| Ventricular Tachycardia |
12.2% |
| Vomiting |
11.4% |
| Small Intestinal Haemorrhage |
8.1% |
| Tinnitus |
7.3% |
| Renal Failure Chronic |
6.5% |
| Hepatitis |
5.7% |
| Hypoglycaemia |
5.7% |
| Electrolyte Imbalance |
4.9% |
| Urinary Retention |
4.9% |
| White Blood Cell Count Increased |
4.9% |
| Interstitial Lung Disease |
4.1% |
| Skin Irritation |
3.3% |
| Sneezing |
3.3% |
| Weight Decreased |
3.3% |
| Bladder Neoplasm |
2.4% |
| Convulsion |
2.4% |
| Dyspnoea |
2.4% |
| Gastrooesophageal Cancer |
2.4% |
| Osteomyelitis |
2.4% |
| Reflux Oesophagitis |
2.4% |
|
| Concomitant |
| Diabetes Mellitus |
20.6% |
| Drug Use For Unknown Indication |
17.1% |
| Product Used For Unknown Indication |
13.4% |
| Hypertension |
11.4% |
| Type 2 Diabetes Mellitus |
8.3% |
| Hyperlipidaemia |
4.4% |
| Prophylaxis |
4.1% |
| Rheumatoid Arthritis |
3.6% |
| Constipation |
1.9% |
| Colon Cancer Metastatic |
1.8% |
| Back Pain |
1.7% |
| Hepatitis C |
1.6% |
| Cerebral Infarction |
1.5% |
| Gastritis |
1.4% |
| Infection Prophylaxis |
1.4% |
| Gastric Ulcer |
1.3% |
| Insomnia |
1.3% |
| Myocardial Infarction |
1.3% |
| Hypercholesterolaemia |
1.2% |
| Multiple Myeloma |
1.2% |
|
| Interstitial Lung Disease |
9.6% |
| Vomiting |
8.0% |
| Cardiac Arrest |
7.2% |
| Renal Failure Acute |
6.4% |
| Renal Impairment |
6.4% |
| White Blood Cell Count Decreased |
5.6% |
| Blood Glucose Increased |
4.8% |
| Hepatic Function Abnormal |
4.8% |
| Phaeochromocytoma Crisis |
4.8% |
| Weight Decreased |
4.8% |
| White Blood Cell Count Increased |
4.8% |
| Bladder Cancer |
4.0% |
| Death |
4.0% |
| Hyperkalaemia |
4.0% |
| Intestinal Obstruction |
4.0% |
| Tremor |
4.0% |
| Blood Potassium Increased |
3.2% |
| Diabetes Mellitus |
3.2% |
| Dizziness |
3.2% |
| Hepatic Failure |
3.2% |
|
